BioCentury
ARTICLE | Company News

Tyg Oncology, Cancer Research UK deal

November 11, 2016 7:40 PM UTC

Tyg and Cancer Research UK (CRUK) partnered to develop Tyg’s TYG100. CRUK will conduct a Phase I trial of TYG100 to treat solid tumors. Upon completion of the trial, Tyg will have the option to retain...

BCIQ Target Profiles

Gastrin